DFX Intelligence
Data Factory
Reading the graph
Reading the graph
CRD 160297
MENLO PARK, CA
Data as of (this record's last observation) from federal regulator filings. Page built and rebuilt at most every 15 minutes.
| Fund | Type | Reported GAV | As of | Owners | First reported | Status | Form D file |
|---|---|---|---|---|---|---|---|
| SOFINNOVA VENTURE PARTNERS X, L.P. | Venture Capital Fund | $803M | Sep 27, 2024 | 59 | Mar 3, 2017 | reported | 021-269425 |
| SOFINNOVA BIOEQUITIES ENHANCED MASTER FUND, LP | Hedge Fund | $766M | Sep 27, 2024 | 18 | Mar 29, 2023 | reported | 021-461670 |
| SOFINNOVA VENTURE PARTNERS IX, L.P. | Venture Capital Fund | $289M | Sep 27, 2024 | 52 | Mar 27, 2015 | reported | 021-220776 |
| SOFINNOVA VENTURE PARTNERS XI, L.P. | Venture Capital Fund | $236M | Sep 27, 2024 | 51 | Mar 30, 2022 | reported | 021-412971 |
| SOFINNOVA BIOEQUITIES MASTER FUND, LTD. | Hedge Fund | $204M | Sep 27, 2024 | 50 | Mar 3, 2017 | reported | 021-286773 |
| SOFINNOVA VENTURE PARTNERS VII, L.P. | Venture Capital Fund | $150M | Feb 19, 2021 | 65 | Mar 30, 2012 | dropped | 021-96426 |
| SOFINNOVA VENTURE PARTNERS VIII, L.P. | Venture Capital Fund | $7.7M | Sep 27, 2024 | 41 | Mar 30, 2012 | reported | 021-162162 |
| SOFINNOVA SYNERGY MASTER FUND, LP | Hedge Fund | $5.1M | Sep 27, 2024 | 13 | Mar 30, 2022 | reported | 021-405750 |
| 80 | Venture Capital Fund | $2.2M | Mar 27, 2014 | 21 | Mar 27, 2014 | dropped | 021-199695 |
| 294 | Venture Capital Fund | $191,747 | Mar 27, 2015 | 8 | Mar 30, 2012 | dropped | 021-9999999999 |
| 94 | Venture Capital Fund | $28,731 | Mar 27, 2015 | 89 | Mar 30, 2012 | dropped | 021-9999999999 |
| 194 | Venture Capital Fund | $3,159 | Mar 27, 2015 | 99 | Mar 30, 2012 | dropped | 021-9999999999 |
| SOFINNOVA VENTURE AFFILIATES VI, L.P. | Venture Capital Fund | $0 | Mar 6, 2017 | 38 | Mar 30, 2012 | dropped | 021-9999999999 |
| SOFINNOVA VENTURE PARTNERS VI, L.P. | Venture Capital Fund | $0 | Mar 6, 2017 | 49 | Mar 30, 2012 | dropped | 021-9999999999 |
| SOFINNOVA VENTURE PARTNERS VI GMBH & CO. K.G. | Venture Capital Fund | $0 | Mar 6, 2017 | 10 | Mar 30, 2012 | dropped | n/a |
| Owner | Title | Ownership code | Control person | Acquired | First seen | Last seen |
|---|---|---|---|---|---|---|
| AUBER, NATHALIE, MARIE | SHAREHOLDER, DIRECTOR AND CHIEF FINANCIAL OFFICER | A | yes | 01/1998 | Mar 3, 2017 | Sep 27, 2024 |
| AZAN, ALAIN, LOUIS | Shareholder | A | yes | 06/1997 | Mar 3, 2017 | Sep 27, 2024 |
| BRODY, JAMES, DENNIS | CHIEF COMPLIANCE OFFICER | Na | yes | 10/2016 | Mar 3, 2017 | Sep 27, 2024 |
| DELBRIDGE, ERIC, HELMUT | Director | Na | yes | 05/2016 | Mar 15, 2024 | Sep 27, 2024 |
| EKMAN, LARS, GOSTA | BOARD OF DIRECTORS MEMBER, EXECUTIVE PARTNER | Na | yes | 09/2016 | Mar 29, 2023 | Sep 27, 2024 |
| HEALY, JAMES, IRVIN | SHAREHOLDER, DIRECTOR | D | yes | 06/2000 | Mar 3, 2017 | Sep 27, 2024 |
| KATABI, MAHA, MEHDI | SHAREHOLDER, DIRECTOR AND VICE PRESIDENT | B | yes | 04/2019 | Mar 31, 2021 | Sep 27, 2024 |
| SHAHLAVI, HOOMAN, NO MIDDLE NAME | SHAREHOLDER, SECRETARY AND CHIEF LEGAL OFFICER | A | yes | 02/2007 | Mar 3, 2017 | Sep 27, 2024 |
| Related person | Type | Class on the graph | Its RAUM | Control | Common control | State |
|---|---|---|---|---|---|---|
| SOFINNOVA BIOEQUITIES GP L.L.C. | n/a | n/a | n/a | N | yes | n/a |
| SOFINNOVA MANAGEMENT IX, L.L.C | n/a | n/a | n/a | N | yes | n/a |
| SOFINNOVA MANAGEMENT VIII, L.L.C. | n/a | n/a | n/a | N | yes | n/a |
| SOFINNOVA MANAGEMENT X-A, L.L.C. | n/a | n/a | n/a | N | yes | n/a |
| SOFINNOVA MANAGEMENT X, L.P. | n/a | n/a | n/a | N | yes | n/a |
| SOFINNOVA MANAGEMENT XI, L.L.C. | n/a | n/a | n/a | N | yes | n/a |
| SOFINNOVA MANAGEMENT XI, L.P. | n/a | n/a | n/a | N | yes | n/a |
| SOFINNOVA SYNERGY FUND GP, L.L.C. | n/a | n/a | n/a | N | yes | n/a |
| City | State | Country | Employees | Also broker-dealer |
|---|---|---|---|---|
| NEW YORK | NY | United States | 4 | no |
| Boston | Ma | United States | 2 | no |
| Montreal | n/a | Canada | 1 | no |
| n/a | n/a | n/a | 1 | no |
| Fiscal year | Filed | RAUM | Discretionary | Employees | Advisory staff | Offices | Private funds | Fund GAV |
|---|---|---|---|---|---|---|---|---|
| 2025 | Mar 27, 2026 | $5.4B | $5.4B | 41 | 20 | 4 | 7 | n/a |
| 2024 | Mar 20, 2025 | $3.8B | $3.8B | 40 | 20 | 4 | 7 | n/a |
| 2023 | Mar 15, 2024 | $4.3B | $4.3B | 35 | 16 | 4 | 7 | $2.3B |
| 2022 | Mar 29, 2023 | $3.7B | $3.7B | 34 | 16 | 5 | 7 | $2.6B |
| 2021 | Mar 30, 2022 | $3.9B | $3.9B | 31 | 15 | 3 | 6 | $2.7B |
| 2020 | Mar 31, 2021 | $3.3B | $3.3B | 32 | 16 | 2 | 4 | $2.4B |
| 2019 | Mar 30, 2020 | $2.8B | $2.8B | 31 | 16 | 3 | 5 | $2.1B |
| 2018 | Mar 28, 2019 | $2.1B | $2.1B | 28 | 13 | 1 | 5 | $1.6B |
| 2017 | Jan 31, 2018 | $1.7B | $1.7B | 27 | 13 | 1 | 5 | $1.6B |
| Latest fiscal year | RAUM | A year earlier | 1y change | Three years earlier | 3y CAGR | Employees | A year earlier | Offices | A year earlier |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $5.4B | $3.8B | 42.3% | $3.7B | 13.1% | 41 | 40 | 4 | 4 |